<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23301007</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Quinacrine impairs enterovirus 71 RNA replication by preventing binding of polypyrimidine-tract binding protein with internal ribosome entry sites.</ArticleTitle><Pagination><StartPage>e52954</StartPage><MedlinePgn>e52954</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e52954</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0052954</ELocationID><Abstract><AbstractText>Since the 1980s, epidemics of enterovirus 71 (EV71) and other enteroviruses have occurred in Asian countries and regions, causing a wide range of human diseases. No effective therapy is available for the treatment of these infections. Internal ribosome entry sites (IRESs) are indispensable for the initiation of translation in enteroviruses. Several cellular factors, as well as the ribosome, are recruited to the conserved IRES during this process. Quinacrine intercalates into the RNA architecture and inhibits RNA transcription and protein synthesis, and a recent study showed that quinacrine inhibited encephalomyocarditis virus and poliovirus IRES-mediated translation in vitro without disrupting internal cellular IRES. Here, we report that quinacrine was highly active against EV71, protecting cells from EV71 infection. Replication of viral RNA, expression of viral capsid protein, and production of virus were all strongly inhibited by quinacrine. Interaction of the polypyrimidine tract-binding protein (PTB) with the conserved IRES was prevented by quinacrine. Coxsackieviruses and echovirus were also inhibited by quinacrine in cultured cells. These results indicate that quinacrine may serve as a potential protective agent for use in the treatment of patients with chronic enterovirus infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jianmin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Jiang</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Zhiqiang</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Qi</ForeName><Initials>Q</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034741">RNA, Small Interfering</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>139076-35-0</RegistryNumber><NameOfSubstance UI="D038941">Polypyrimidine Tract-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>H0C805XYDE</RegistryNumber><NameOfSubstance UI="D011796">Quinacrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020128" MajorTopicYN="N">Inhibitory Concentration 50</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010957" MajorTopicYN="N">Plasmids</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038941" MajorTopicYN="N">Polypyrimidine Tract-Binding Protein</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011796" MajorTopicYN="N">Quinacrine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034741" MajorTopicYN="N">RNA, Small Interfering</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012208" MajorTopicYN="N">Rhabdomyosarcoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012270" MajorTopicYN="N">Ribosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23301007</ArticleId><ArticleId IdType="pmc">PMC3536785</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0052954</ArticleId><ArticleId IdType="pii">PONE-D-12-32945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liao HT, Hung KL (2001) Neurologic involvement in an outbreak of enterovirus 71 infection: a hospital-based study. Acta Paediatr Taiwan 42: 27&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">11270182</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, Davis S (2001) Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 32: 236&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, He Y, Yang H, Zhu J, Xu X, et al. (2005) Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 43: 3835&#x2013;3839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1233905</ArticleId><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, et al. (2007) Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med 356: 1226&#x2013;1234.</Citation><ArticleIdList><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SK, Pestova TV, Hellen CU, Witherell GW, Wimmer E (1990) Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme 44: 292&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">1966843</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen CU, Sarnow P (2001) Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev 15: 1593&#x2013;1612.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445534</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown EA, Day SP, Jansen RW, Lemon SM (1991) The 5&#x2032; nontranslated region of hepatitis A virus RNA: secondary structure and elements required for translation in vitro. J Virol 65: 5828&#x2013;5838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250245</ArticleId><ArticleId IdType="pubmed">1656072</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda M, Brown EA, Lemon SM (1996) Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA 2: 955&#x2013;968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369429</ArticleId><ArticleId IdType="pubmed">8849773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen CU, Wimmer E (1995) Translation of encephalomyocarditis virus RNA by internal ribosomal entry. Curr Top Microbiol Immunol 203: 31&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">7555090</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson RJ, Howell MT, Kaminski A (1990) The novel mechanism of initiation of picornavirus RNA translation. Trends Biochem Sci 15: 477&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">2077688</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer E, Hellen CU, Cao X (1993) Genetics of poliovirus. Annu Rev Genet 27: 353&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">8122908</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerovitch K, Svitkin YV, Lee HS, Lejbkowicz F, Kenan DJ, et al. (1993) La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J Virol 67: 3798&#x2013;3807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237744</ArticleId><ArticleId IdType="pubmed">8389906</ArticleId></ArticleIdList></Reference><Reference><Citation>Svitkin YV, Meerovitch K, Lee HS, Dholakia JN, Kenan DJ, et al. (1994) Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J Virol 68: 1544&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236611</ArticleId><ArticleId IdType="pubmed">8107217</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest S, Pilipenko E, Sharma K, Chumakov K, Roos RP (2004) Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J Virol 78: 11097&#x2013;11107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC521805</ArticleId><ArticleId IdType="pubmed">15452230</ArticleId></ArticleIdList></Reference><Reference><Citation>Gosert R, Chang KH, Rijnbrand R, Yi M, Sangar DV, et al. (2000) Transient expression of cellular polypyrimidine-tract binding protein stimulates cap-independent translation directed by both picornaviral and flaviviral internal ribosome entry sites In vivo. Mol Cell Biol 20: 1583&#x2013;1595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC85342</ArticleId><ArticleId IdType="pubmed">10669736</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, et al. (1999) Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res 61: 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig ME, Vale T, Robertson P, Rawlinson WD, Gould B (1999) Enterovirus 71 infection in Australian expatriate children following an outbreak in Malaysia. J Paediatr Child Health 35: 107&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">10234649</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Lindsay K, Perera D, Chan HM, Chan KP, et al. (2001) Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 75: 7732&#x2013;7738.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC115010</ArticleId><ArticleId IdType="pubmed">11462047</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, et al. (1999) Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997&#x2013;1998. Jpn J Infect Dis 52: 12&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">10808253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto T, Chikahira M, Yoshida S, Ebira H, Hasegawa A, et al. (2002) Outbreak of central nervous system disease associated with hand, foot, and mouth disease in Japan during the summer of 2000: detection and molecular epidemiology of enterovirus 71. Microbiol Immunol 46: 621&#x2013;627.</Citation><ArticleIdList><ArticleId IdType="pubmed">12437029</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu PY, Lin KH, Hwang KP, Chou LC, Wang CF, et al. (2001) Molecular epidemiology of enterovirus 71 in Taiwan. Arch Virol 146: 589&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">11338392</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F, Ren L, Xiong Z, Li J, Xiao Y, et al. (2009) Enterovirus 71 outbreak in the People's Republic of China in 2008. J Clin Microbiol 47: 2351&#x2013;2352.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2708525</ArticleId><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY (2003) Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 9: 291&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2963902</ArticleId><ArticleId IdType="pubmed">12643822</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnuevo JG (1950) Quinacrine and new antimalarial drugs in the treatment of giardiasis. Rev Kuba Med Trop Parasitol 6: 121&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">14808888</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnuevo JG, Cowley Chavez O, Soler Delgado F (1952) Simplified treatment of giardiasis with quinacrine during 12 hours. Rev Kuba Med Trop Parasitol 8: 67&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">13101018</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson F (1953) Quinacrine therapy of tapeworm infection. Sven Lakartidn 50: 239&#x2013;242.</Citation><ArticleIdList><ArticleId IdType="pubmed">13077212</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Rao NL, Venable J, Thurmond R, Karlsson L (2007) TLR7/9 antagonists as therapeutics for immune-mediated inflammatory disorders. Inflamm Allergy Drug Targets 6: 223&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">18220957</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, et al. (2006) The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus. Scand J Immunol 63: 299&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">16623930</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace DJ (1989) The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. Semin Arthritis Rheum 18: 282&#x2013;296.</Citation><ArticleIdList><ArticleId IdType="pubmed">2658071</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse MW, Bostrom H (1965) Biochemical properties of anti-inflammatory drugs. VI. The effects of chloroquine (resochin), mepacrine (quinacrine) and some of their potential metabolites on cartilage metabolism and oxidative phosphorylation. Biochem Pharmacol 14: 1173&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pubmed">4221789</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbachev AV, Gasparian AV, Gurova KV, Gudkov AV, Fairchild RL (2007) Quinacrine inhibits the epidermal dendritic cell migration initiating T cell-mediated skin inflammation. Eur J Immunol 37: 2257&#x2013;2267.</Citation><ArticleIdList><ArticleId IdType="pubmed">17634953</ArticleId></ArticleIdList></Reference><Reference><Citation>Doh-Ura K, Iwaki T, Caughey B (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J Virol 74: 4894&#x2013;4897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC112015</ArticleId><ArticleId IdType="pubmed">10775631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi Y, Hirata K, Tanaka H, Yamada T (2003) Quinacrine administration to a patient with Creutzfeldt-Jakob disease who received a cadaveric dura mater graft&#x2013;an EEG evaluation. Rinsho Shinkeigaku 43: 403&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">14582366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, et al. (2005) Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci U S A 102: 17448&#x2013;17453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1297696</ArticleId><ArticleId IdType="pubmed">16287968</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Nottingham L, Duggal P, Pernas FG, Yan B, et al. (2007) Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer. Clin Cancer Res 13: 6568&#x2013;6578.</Citation><ArticleIdList><ArticleId IdType="pubmed">18006756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zipper J, Cole LP, Goldsmith A, Wheeler R, Rivera M (1980) Quinacrine hydrochloride pellets: preliminary data on a nonsurgical method of female sterilization. Int J Gynaecol Obstet 18: 275&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pubmed">6109672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard NJ, Blake A, Peacocke AR (1966) Modified intercalation model for the interaction of amino acridines and DNA. Nature 212: 1360&#x2013;1361.</Citation><ArticleIdList><ArticleId IdType="pubmed">5967015</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien RL, Olenick JG, Hahn FE (1966) Reactions of quinine, chloroquine, and quinacrine with DNA and their effects on the DNA and RNA polymerase reactions. Proc Natl Acad Sci U S A 55: 1511&#x2013;1517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC224352</ArticleId><ArticleId IdType="pubmed">5336287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha R, Hossain M, Kumar GS (2007) RNA targeting by DNA binding drugs: structural, conformational and energetic aspects of the binding of quinacrine and DAPI to A-form and H(L)-form of poly(rC).poly(rG). Biochim Biophys Acta 1770: 1636&#x2013;1650.</Citation><ArticleIdList><ArticleId IdType="pubmed">17942232</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M, Suresh Kumar G (2009) DNA intercalation of methylene blue and quinacrine: new insights into base and sequence specificity from structural and thermodynamic studies with polynucleotides. Mol Biosyst 5: 1311&#x2013;1322.</Citation><ArticleIdList><ArticleId IdType="pubmed">19823747</ArticleId></ArticleIdList></Reference><Reference><Citation>Malina A, Khan S, Carlson CB, Svitkin Y, Harvey I, et al. (2005) Inhibitory properties of nucleic acid-binding ligands on protein synthesis. FEBS Lett 579: 79&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">15620694</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasparian AV, Neznanov N, Jha S, Galkin O, Moran JJ, et al. (2010) Inhibition of encephalomyocarditis virus and poliovirus replication by quinacrine: implications for the design and discovery of novel antiviral drugs. J Virol 84: 9390&#x2013;9397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2937643</ArticleId><ArticleId IdType="pubmed">20631142</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZH, Li CM, Ling P, Shen FH, Chen SH, et al. (2008) Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 197: 854&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Wu Z, Jin Q (2012) COPI is required for enterovirus 71 replication. PLoS One 7: e38035.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3360637</ArticleId><ArticleId IdType="pubmed">22662263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung HC, Chen TC, Fang MY, Yen KJ, Shih SR, et al. (2010) Inhibition of enterovirus 71 replication and the viral 3D polymerase by aurintricarboxylic acid. J Antimicrob Chemother 65: 676&#x2013;683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7110181</ArticleId><ArticleId IdType="pubmed">20089540</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Yang F, Zhao R, Zhao L, Guo D, et al. (2009) Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. J Virol Methods 159: 233&#x2013;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">19490979</ArticleId></ArticleIdList></Reference><Reference><Citation>Novac O, Guenier AS, Pelletier J (2004) Inhibitors of protein synthesis identified by a high throughput multiplexed translation screen. Nucleic Acids Res 32: 902&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC373382</ArticleId><ArticleId IdType="pubmed">14769948</ArticleId></ArticleIdList></Reference><Reference><Citation>Borman A, Howell MT, Patton JG, Jackson RJ (1993) The involvement of a spliceosome component in internal initiation of human rhinovirus RNA translation. J Gen Virol 74 Pt 9: 1775&#x2013;1788.</Citation><ArticleIdList><ArticleId IdType="pubmed">8397279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen CU, Witherell GW, Schmid M, Shin SH, Pestova TV, et al. (1993) A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A 90: 7642&#x2013;7646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC47198</ArticleId><ArticleId IdType="pubmed">8395052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaminski A, Hunt SL, Patton JG, Jackson RJ (1995) Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1: 924&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1369341</ArticleId><ArticleId IdType="pubmed">8548657</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H (1938) A simple method of estimating fifty per cent endpoints. American Journal of Epidemiology 27: 493.</Citation></Reference><Reference><Citation>Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC55695</ArticleId><ArticleId IdType="pubmed">11328886</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkirk JV, Nottebaum LM, Ford IC, Santos M, Malany S, et al. (2006) A novel cell-based assay for G-protein-coupled receptor-mediated cyclic adenosine monophosphate response element binding protein phosphorylation. J Biomol Screen 11: 351&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">16751331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>